JB/CALL/MODERNA/130/0.0166/20.09.24 Share Price

Warrant

MRZNJB

CH1280665535

Market Closed - Swiss Exchange 08:50:00 14/06/2024 pm IST
0.35 CHF -12.50% Intraday chart for JB/CALL/MODERNA/130/0.0166/20.09.24
Current month-18.60%
1 month+45.83%
Date Price Change
14/24/14 0.35 -12.50%
12/24/12 0.4 -4.76%
11/24/11 0.42 +2.44%
10/24/10 0.41 -12.77%
07/24/07 0.47 -9.62%

Delayed Quote Swiss Exchange

Last update June 14, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MODERNA, INC.
Issuer Bank Julius Bär
MRZNJB
ISINCH1280665535
Date issued 07/08/2023
Strike 130 $
Maturity 20/09/2024 (97 Days)
Parity 60 : 1
Emission price 0.27 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 0.68 CHF
Lowest since issue 0.06 CHF
Spread 0.01 CHF
Spread %2.86%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
140 USD
Average target price
145.2 USD
Spread / Average Target
+3.67%
Consensus
  1. Stock Market
  2. Warrants
  3. MRZNJB Warrant